Latest News & Updates
Prostate cancer that emerges when a man is 55 years of age or younger is a distinct phenotype of the disease, and should be treated and researched accordingly,
This review highlights that preclinical data and discusses several ongoing clinical trials that are leveraging this information to explore new therapeutic strategies in targeting BRAF-mutated colorectal cancer.
A number of large pharmaceutical companies have forged clinical trial collaborations focused on the investigation of novel combinations and companion diagnostics across multiple cancer indications.
A genomic analysis of renal cell carcinoma (RCC) has uncovered new clues about the development, growth, and spread of the cancer.
A randomized multicenter trial examining the efficacy of adding dehydroepiandosterone (DHEA) to a vaginal bioadhesive moisturizer in postmenopausal survivors of breast or gynecologic cancer has found that daily rather than as-needed use of such a moisturizer significantly relieves symptoms of vaginal atrophy in these women.
Latest Peer Exchange Discussions
Panelists discuss future analyses that will be conducted on the vast amount of data collected from the phase III CALGB/SWOG 80405 trial that examined upfront chemotherapy plus bevacizumab or cetuximab in patients with metastatic colorectal cancer. View Now
In this segment, the panelists discuss the use of different dosing schedules for targeted agents in renal cell carcinoma. View Now
Barbara Murphy, MD, and Ezra Cohen, MD, discuss the role of oncology nurses in the management of toxicities associated with head and neck cancer treatment. View Now
Most Popular Right Now
Online CME Activities